Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Financings

Comprehensive Healthcare Systems Announces Extension of Second Tranche of Private Placement

CHS · Price

Executive Summary

  • Comprehensive Healthcare Systems Inc. announced an extension of its non‑brokered private placement for up to an additional 4,038,462 Units at $0.52 per Unit, potentially raising up to $2.1 million.
  • The original tranche of 7,000,000 Units at $0.50 per Unit was closed on February 10 2026, providing $3.5 million in gross proceeds.
  • Each Unit consists of one common share and half a warrant (full warrant exercisable at $1.00 for three years), with the extension allowing participation by the controlling shareholder subject to overseas regulatory processes.

Key Details

  • Original Offering (closed Feb 10, 2026): 7,000,000 Units @ $0.50 per Unit → $3.5 M gross proceeds.
  • Extension Offering: Up to 4,038,462 Units @ $0.52 per Unit → up to $2.1 M gross proceeds.
  • Total potential raise (original + extension): ≈ $5.6 million.
  • Unit composition: 1 common share + ½ warrant; each full warrant allows purchase of one additional share at $1.00 exercise price, exercisable for three years post‑closing.
  • Extension deadline: New subscription period ends April 13, 2026 (30‑day extension).
  • Purpose of extension: Accommodate subscription by the controlling shareholder who must complete overseas compliance steps.
  • Closing conditions: Subject to customary closing conditions, including receipt of all required approvals (e.g., TSX Venture Exchange) and securities law hold periods.
  • Finder fees: Company may pay finder fees in accordance with applicable laws and exchange approval.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Comprehensive Healthcare Systems Inc.